West Pharmaceutical Services (WST) Osake Kurssi
West Pharmaceutical Services Kurssi
Viimeisten 19 vuoden aikana West Pharmaceutical Servicesn liikevaihto kasvoi 6,6 % vuodessa ja ylsi 3,07 Mrd. USD:een. Osakekohtainen tulos on kasvanut 10,8 % vuodessa viimeisten 19 vuoden aikana. West Pharmaceutical Servicesn nettomarginaali 16,1 % on laskenut verrattuna 23,4 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,21 %. Jakosuhde on noin 13 % tuloksesta. Osinko on kasvanut 6,8 % vuodessa viimeisten 19 vuoden aikana. West Pharmaceutical Servicesn 12 kuukauden konsensustavoitehinta on 400,00 USD, noin yli kurssia 0,4 %. 22 analyytikosta 21 suosittaa ostoa — kokonaiskonsensus on Osta.
West Pharmaceutical Services osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
West Pharmaceutical Services liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset West Pharmaceutical Services -osakkeesta
The business model of West Pharmaceutical Services Inc. revolves around the manufacturing and distribution of innovative packaging and delivery solutions for the pharmaceutical and healthcare industries. West Pharmaceutical specializes in the development and production of advanced systems, such as drug delivery systems, injectable components, and analytical lab services. With a strong focus on quality, safety, and patient outcomes, West Pharmaceutical collaborates with pharmaceutical companies worldwide to provide customized packaging solutions that enhance the stability, efficacy, and convenience of drug delivery. By leveraging their expertise in materials science, engineering, and technology, West Pharmaceutical Services Inc. positions itself as a trusted partner in supporting the global healthcare industry.
West Pharmaceutical Services Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of West Pharmaceutical Services Inc in the market are Becton, Dickinson and Company (BD), Catalent Inc, and Gerresheimer AG.
West Pharmaceutical Services Inc, founded in 1923, is a global leader in innovative solutions for injectable drug administration. With a rich history spanning nearly a century, the company has continuously evolved to meet the needs of the healthcare industry. West specializes in designing and manufacturing packaging and delivery systems for pharmaceuticals, such as vials, syringe components, and auto-injectors. Their cutting-edge technologies ensure drug containment, administration, and patient safety. Recognized for excellence in quality and reliability, West serves pharmaceutical, biotechnology, and generics companies worldwide. With a commitment to advancing healthcare, West Pharmaceutical Services Inc is at the forefront of enabling the safe and efficient delivery of life-saving medications.
West Pharmaceutical Services Inc has achieved several significant milestones. It has become a global leader in innovative solutions for injectable drug administration, serving pharmaceutical, biotechnology, and healthcare industries. The company has successfully expanded its global footprint, establishing manufacturing facilities and expanding operations in various regions. It has consistently focused on research and development, resulting in the introduction of cutting-edge technologies and advanced products. West Pharmaceutical Services Inc has also prioritized sustainability initiatives, promoting eco-friendly practices and reducing its environmental impact. Overall, the company's dedication to excellence, global expansion, technological advancements, and environmental consciousness have been key milestones in its success.
West Pharmaceutical Services Inc is primarily present in various countries and regions around the world. The company has a strong global presence and operates in multiple key markets. Some of the prominent countries and regions where West Pharmaceutical Services Inc has a significant presence include the United States, Europe, Asia-Pacific, and Latin America. Its commitment to delivering innovative solutions and high-quality products has helped establish a strong foothold in these markets. With its global reach, West Pharmaceutical Services Inc continues to expand its operations and serve customers across different regions.
West Pharmaceutical Services Inc represents a commitment to quality, innovation, and patient safety. As a global leader in pharmaceutical packaging and delivery systems, the company focuses on providing solutions that ensure the integrity and efficacy of drug products. With a corporate philosophy centered on collaboration, West strives to enable its customers' success by understanding their needs and delivering reliable, advanced technologies. By consistently putting patient well-being at the forefront, West aims to enhance the global healthcare landscape through its cutting-edge products and services.
Analyytikot asettavat tällä hetkellä West Pharmaceutical Services-osakkeelle keskimääräisen tavoitehinnan 405,40 USD (mediaani: 400,00 USD), mikä merkitsee +4,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 22 analyytikkoarvioon.
West Pharmaceutical Services Analyytikkojen kursstavoitteet 2026
22 analyytikkoa arvioi tällä hetkellä West Pharmaceutical Services-osaketta: 21 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat West Pharmaceutical Services-yhtiöltä 3,38 Mrd. USD liikevaihtoa ja 8,98 USD osakekohtaista tulosta.
West Pharmaceutical Services Analyytikkojen kursstavoitteet 2026
Nykyisellä valuuttakurssilla West Pharmaceutical Services-osake noteerataan hintaan 356,04 EUR (398,29 USD).
West Pharmaceutical Services-osake (WST) on listattuna 6 pörssissä, muun muassa: NYSE (WST), SIX (Zürich) (WPS.SW), XETRA (WPS.DE), Frankfurt (WPS.F), München (WPS.MU), Düsseldorf (WPS.DU).
West Pharmaceutical Services Inc. is a leading provider of innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. The company was founded in 1923 and is headquartered in Exton, Pennsylvania, USA. The business model of West Pharmaceutical Services Inc. is based on three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. In each of these divisions, the company offers various products and services to meet the needs of its customers. Primary Packaging In the Primary Packaging division, West Pharmaceutical Services offers various products used for the packaging of drugs. These include stoppers, vials, caps, closures, and various other components. West Pharmaceutical Services specializes in innovative packaging solutions that help increase the safety and efficacy of medications. This includes special coatings that enhance the barrier properties of the packaging and reduce the ingress of oxygen and moisture. Drug Delivery Systems The Drug Delivery Systems division includes a wide range of products used for the administration of medications. These include syringes, pens, auto-injectors, nasal sprays, powder inhalers, and various other systems. West Pharmaceutical Services develops innovative solutions that contribute to the safe and uncomplicated administration of medications. The focus is on improving patient safety. Healthcare Analytics In the Healthcare Analytics division, West Pharmaceutical Services uses modern technologies to collect and analyze health data. The aim is to fill information gaps and enable better decision-making in healthcare. The data analysis and visualization provided by West Pharmaceutical Services help healthcare providers identify trends, make predictions, and improve treatment outcomes. Summary West Pharmaceutical Services offers innovative packaging and delivery systems for the pharmaceutical, biotechnology, and medical industries. It serves three main divisions: Primary Packaging, Drug Delivery Systems, and Healthcare Analytics. The company strives to improve the safety and efficacy of medications and enhance patient safety. Through the analysis of health data, the company contributes to making the healthcare system more efficient and cost-effective.
odotettu liikevaihto West Pharmaceutical Services on 3,38 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto West Pharmaceutical Services on 652,55 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
West Pharmaceutical Services:n hinta-voitto-suhde (P/E) on tällä hetkellä 44,37. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan West Pharmaceutical Services-osakkeen arvostusta.
West Pharmaceutical Services:n hinta-myynti-suhde (P/S) on tällä hetkellä 8,58. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii West Pharmaceutical Services-osakkeen arvostuskennuslukuna.
West Pharmaceutical Services:n Eulpool-laatuscore on 6/10.
West Pharmaceutical Services:n ISIN on US9553061055. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
West Pharmaceutical Services:n WKN on 864330. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
West Pharmaceutical Services:n ticker on WST. Tämä pörssinoteeraus käytetään West Pharmaceutical Services-osakkeiden kauppaan pörssissä.
West Pharmaceutical Services osake
West Pharmaceutical Services vertaisryhmä
West Pharmaceutical Services Ticker
West Pharmaceutical Services FIGI
Kaikki tunnusluvut ja syvällinen analyysi West Pharmaceutical Services:sta
Meidän osakeanalyysimme West Pharmaceutical Services-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut West Pharmaceutical Services:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: